Top Markets
Coin of the day
Avisa Diagnostics Inc. Avisa Diagnostics Inc.

Avisa Diagnostics Inc.

AVBT
Clasificación en acciones #40597
Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa... Avisa Diagnostics Inc., a clinical-stage medical device company based in Santa Fe, New Mexico, is dedicated to developing the Avisa BreathTest. This innovative drug/device biomarker technology platform is designed for the ultra-rapid identification of virulent bacterial pathogens and the subsequent monitoring of bacterial load. The system works by analyzing a patient's breath after they have inhaled or ingested Avisa's proprietary drug substrates. The company has already established clinical proof-of-concept through trials in conditions such as cystic fibrosis, tuberculosis, and community-acquired pneumonia, and is now concentrating on pivotal trials for Post-COVID-19 bronchiectasis and ventilator-associated pneumonia.
Precio por acción
$0.0333321
Última sincronización: 2023-05-23
Capitalización bursátil
$114.40K
Cambio (1 día)
-0.04%
Cambio (1 año)
0.00%
País
US
Comercio Avisa Diagnostics Inc. (AVBT)

Categoría

Ganancias de Avisa Diagnostics Inc. (AVBT)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Avisa Diagnostics Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Avisa Diagnostics Inc. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US